Debt to EBITDA ratio Analysis of Immuneering Corp - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of IMRX
Dec-23-5.91Very Poor Debt to EBITDA | Dec-22-0.0075Very Poor Debt to EBITDA | Growth-78732.68% |
Debt to EBITDA Analysis of Immuneering Corp
| Debt to EBITDA Ratio of IMRX drastically fell by -78732.68 % this year. |
| Debt to EBITDA Ratio with value of 0 was highest in Year Dec-19 in last Five Years. |
| Debt to EBITDA Ratio with value of -5.91 was lowest in Year Dec-23 in last Five Years. |
| Latest Debt to EBITDA Ratio with value of -5.91 is lower than Average Debt to EBITDA of -1.19 in last five years. |
Other Debt to EBITDA Related Info of IMRX that may interest you.
Immuneering Corp Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| IMRX | 1.47 | 1.54 | 4.55 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| Mild Stability | |
FY - Historical Debt to EBITDA of Immuneering Corp
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 |
|---|---|---|---|---|---|
| Debt to EBITDA | -5.91 | -0.0075 | -0.0081 | -0.0045 | 0 |
| Change | -78732.68 % | 7.41 % | -79.94 % |
FY Chart of Debt to EBITDA of Immuneering Corp
Note : All Data Generated at the End of Trading Hours (EOD Data)